Page last updated: 2024-08-23

1-deoxynojirimycin and glycoprotein e2, hepatitis c virus

1-deoxynojirimycin has been researched along with glycoprotein e2, hepatitis c virus in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bartosch, B; Chapel, C; Cosset, FL; Dubuisson, J; Durantel, D; Dwek, RA; Garcia, C; Roingeard, P; Trépo, C; Zitzmann, N; Zoulim, F	1

Other Studies

1 other study(ies) available for 1-deoxynojirimycin and glycoprotein e2, hepatitis c virus

Article	Year
Reduction of the infectivity of hepatitis C virus pseudoparticles by incorporation of misfolded glycoproteins induced by glucosidase inhibitors. The Journal of general virology, 2007, Volume: 88, Issue:Pt 4 Topics: 1-Deoxynojirimycin; Antiviral Agents; Cell Line; Enzyme Inhibitors; Glucosamine; Glycoside Hydrolase Inhibitors; Glycosylation; Hepacivirus; Humans; Luciferases; Microscopy, Immunoelectron; Protein Binding; Protein Folding; Viral Envelope Proteins; Virus Replication	2007

Article

Year

Reduction of the infectivity of hepatitis C virus pseudoparticles by incorporation of misfolded glycoproteins induced by glucosidase inhibitors.

The Journal of general virology, 2007, Volume: 88, Issue:Pt 4

Topics: 1-Deoxynojirimycin; Antiviral Agents; Cell Line; Enzyme Inhibitors; Glucosamine; Glycoside Hydrolase Inhibitors; Glycosylation; Hepacivirus; Humans; Luciferases; Microscopy, Immunoelectron; Protein Binding; Protein Folding; Viral Envelope Proteins; Virus Replication

2007